Skip to main content

Trinity College Dublin, The University of Dublin

Menu Search


Trinity College Dublin By using this website you consent to the use of cookies in accordance with the Trinity cookie policy. For more information on cookies see our cookie policy.

      
Profile Photo

Dr. Fabio Boylan

Associate Professor (Pharmacy)
25/6/7 WESTLAND ROW
      
Profile Photo

Dr. Fabio Boylan

Associate Professor (Pharmacy)
25/6/7 WESTLAND ROW


Born in Rio de Janeiro, Brazil, in 15 of February of 1972. Fabio Boylan studied Pharmacy at Rio de Janeiro Federal University, in Rio de Janeiro, Brazil. From February 1996 to February 1998, he was Lecturer at the Department of Pharmacognosy, Faculdade de Farmacia, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil. His Master project "Phylogenetic Trends within Lamiiflorae" was sponsored by CNPq, a Brazilian Governmental Agency for 1.5 years and he got the degree after being evaluated by Dr. Otto Richard Gottlieb. His Ph.D. project "Chemical and Pharmacological Studies on Raphiodon echinus and Marsypianthes chamaedrys" was sponsored by CAPES, another Brazilian Governmental Agency. In several years he was awarded with grants from FAPERJ (Rio de Janeiro Research Supporting Agency) and FINEP in 2003 when he had the opportunity to chair the XII Italian-Latin-American Conference on Ethnomedicine. Also in 2003 he was awarded with a special grant from CNPq due to his scientific collaboration to the Brazilian Science. Fabio stepped up as a senior lecturer at the Faculty of Pharmacy, Federal University of Rio de Janeiro in 1998. In 2006, he started his sabbatical year in the School of Pharmacy and Pharmaceutical Sciences, TCD, where he further served as a research coordinator from 2007-2008 and now is a full time lecturer in Pharmacognosy. He acts an ad hoc reviewer for the following scientific journals: Brazilian Journal of Pharmacognosy, Brazilian Journal of Medicinal Plants, Brazilian Journal of Microbiology, Brazilian Journal of Pharmaceutical Sciences, Phytochemistry, Iheringia Zoologia (Section Botany), Phytotherapy Research, Current Medicinal Chemistry, African Journal of Pharmacology and Pharmaceutical Sciences, Molecules, Frontiers in Pharmacology, Antioxidants, Journal of Chromatography, among others.
  Antiinflammatory drugs   Biochemistry, metabolism   Chemistry of drug metabolism   Chemistry of drug receptor interactions   Development of drugs for malaria, Cancer and inflammatory diseases   Drug development   Drug discovery   Herbal medicine   Medicinal Chemistry   Medicinal plants   Microencapsulation methodologies   Molecular markers and recognition   Molecular systematics   Organic chemistry   Pharmaceutical products   Pharmacognosy   Pharmacological Sciences   Phytochemical and pharmacological evaluations of native and foreign plants   Phytomedicines   Plant and algal cell monocultures   Plant Biochemistry   Plant biology   Plant systematics   Plant tissue culture   Secondary plant metabolism   Traditional and Indigenous health systems in developing countries
Project Title
 Orbignya speciosa (Arecacea) as a potencial source of novel therapeutic agents: from traditional medicine information to the pharmacological evaluation of its chemical constituents.
From
To
Summary
The aim of this project is to check the validity of the ethnopharmacological information for Orbignya speciosa in folk medicine. This plant is used, among other purposes, for the treatment of leukaemia and inflammatory conditions. Using modern techniques of isolation and purification of natural products and up-to-date spectroscopy techniques we aim to isolate the constituents responsible for such activities. It is also intended to test the activity for the extracts and isolates using in vivo (mice) and in vitro (cell culture) methodologies, allied to techniques in molecular pharmacology: DNA-fragmentation, electrophoresis, zymography, western-blot, apoptosis studies (flow cytometry), microscopy (SEM) among others.
Project Title
 Chemical and pharmacological studies on Jambu and Piquia, two medicinal plants from the Amazon Region: development of new health products with nutraceutical and medicinal properties.
From
2021
To
Summary
Acmella oleracea (Jambu) and Caryocar villosum (Piquiá) are two edible plants from the Amazon Region in Brazil. They are part of the local cuisine but also used as medicines to treat cancer. Metabolomic analysis will be employed for the study of the full chemical composition of these two species, using liquid chromatography coupled to mass spectrometry. Isolation of compounds for pharmacological assays will be performed by the use of High-Speed Counter Current Chromatography. Appropriate synthetic strategies will be used to allow for the preparation of large enough quantities of material to be assayed pharmacologically. The pharmacological activity for these two species will be also be assessed using Zebrafish methodology, and specifically the anticancer activity will be determined in cell culture using prostate, breast, intestine and lung cancer cell lines. These four cancers represent the highest incidence of mortality by cancer in Ireland. After standardisation of both chemistry and pharmacology, we envisage to prepare a formulation using modern technology for the development of a food supplement, potentially to be used as chemopreventative. As a long-term goal, we will be setting the basis for the development of a new medicine to treat symptoms associated with cancer.
Project Title
 Chemical and Pharmacological studies on Medicinal Plants from Kazakh Flora
From
To
Summary
Continue the research developed in conjunction with the Republic of Kazakhstan, in the Kazakh National Medical University, specifically in the area of Natural Products aiming to help them to validate their indigenous knowledge and to try and build their own identity in terms of pharmaceutical natural products to enter in their own pharmacopoeia. So using similar approach to the ethnopharmacological knowledge of their plants, the aim is the validation of chemical and pharmacological properties of endemic plants allowing for their inclusion in the National Pharmacopoeia.
Project Title
 Investigation on the anti-inflammatory properties of selected Saudi Medicinal Plants and correlation of their activity with their chemistry
From
To
Summary
People of Saudi Arabia and the Arabian Peninsula, in general, have been using medicinal plants to heal various routine maladies and chronic diseases including skin-related diseases, rheumatism, bone fracture, asthma, diabetes, and eye and ear problems. This unique relationship with the flora continues to this day as people still rely heavily on folklore and traditional medicine to meet their healthcare needs despite of the presence of modern hospitals and well-trained medical staff. However, these traditional practices and folklore, don't specifically present a rational and defined picture of such plants, often using many terms indiscriminately and mixing or distortion of many facts. Often the traditional medicine presents an abstract explanation and consists of imaginative information that can be misleading. Hence the need of a scientific study to evaluate those claims. In this study five medicinal plants widely used in Saudi Arabia as an analgesic and for inflammatory diseases are selected and being studied in order to assess whether the pharmacological activities that have been reported for them is in fact justifiable. The selection criteria for the plants to be studied was based on their ethnopharmacology, and their availabilities. The main aim of this study is to provide the scientific evidence for the reputed efficacy of the Saudi traditional medicinal plants Artemisia judaica, Pistacia falcata Capparis cartilaginea, Lavandula dentata, and Lavandula pubescens, in the maintenance of inflammatory conditions as possessing analgesic and anti-inflammatory activities. This study will also examine the volatile composition of two Lavandula species (dentata, and Lavandula pubescens) collected monthly for one year in order evaluate the chemical variation and establish the best time for collection for medicinal purposes and drug development. The specific objectives are: 1. To investigate extracts from A. judaica, P. falcata C. cartilaginea, L. dentata, and L. pubescens for anti-inflammatory and antinociceptive activities. 2. To isolate, purify and identify bioactive compounds from A. judaica, P. falcata C. cartilaginea, L. dentata, and L. pubescens. 3. To prepare Nano-formulations containing the plant extracts. 4. To evaluate the antinociceptive and anti-inflammatory activities of the plant extracts and isolates through formalin-induced, acetic acid-induced and hot plate models. 5. To carry out Multivariate analysis in order to characterize and compare the phytochemical constituents from L. dentata, and L. pubescens samples collected monthly. This study may be of great help for chemotaxonomic purposes, the interpretation of medicinal properties and for quality assessment of herbal supplements containing Lavandula leaves. 3. Research Questions. The main question for this research is 'Do Artemisia Judaica, Pistacia falcata Capparis cartilaginea, Lavandula dentata, and Lavandula pubescens have anti-inflammatory and antinociceptive activities? These questions are further divided into following questions; · What are the compounds responsible for the biological activities? · How effective are these natural compounds in curing the symptoms inflammatory diseases? This study will also answer the questions: · What are the major phytochemical differences between L. dentata and L. Pubescence? · Which compounds are essential for anti-inflammatory activity?
Project Title
 The scents of St. Stephen's Green: would a Dublin city centre park be hiding a chemical treasure?
From
To
Summary
St. Stephen"s Green park houses over 100 species of plants belonging to over 20 different botanical families. This project proposes the investigation of the essential oil (EO) constituents of all plants growing in the park using two different methodologies - microwave-assisted extraction and headspace. The oil composition will be analysed via gas chromatography coupled with mass spectroscopy. In the event of unknown chemical compounds, their structures will be confirmed by means of synthesis. EOs and EO constituents will be assayed against a panel of normal and cancer cell lines. The potential mechanism of their anticancer activity will be investigated for the EOs and EO constituents using viability and proliferative cell assays, flow cytometry, ELISA and immunoblotting. The best candidates from those with the highest anticancer activity will be formulated using reverse micellar and silver nanoparticle production. The resultant successful nanoformulations will be fully characterised, and their effect will be evaluated once again in vitro

Details Date
Reviewer for the Estonian Research Council - As an external reviewer for the Estonian Research Council (ETAG), duties include independently assessing assigned grant applications for scientific quality, originality, feasibility and applicant competence; providing written, scored evaluations; declaring any conflicts of interest; maintaining confidentiality throughout; and submitting recommendations that feed into the Evaluation Committee's funding decisions. 2026
Secretary of the Phytochemical Society of Portugal (SPFito). The Secretary maintains membership records and correspondence, drafts and keeps minutes of General Assembly and Board meetings, handles official communications and documentation, supports organisation of events/activities, and assists the President in day-to-day administrative running of the Society. 2026
Committee for the Academic Council of Faculty of Pharmacy- Department of Pharmacy, Al-Zaytoonah University of Jordan, to assess the research of Dr. Al-Zaytoonah University of Jordan, who has applied for promotion to the status of Associate Professor. As a member of this Academic committee, my duties included reviewing the candidate's publications, research output and academic contributions; assessing their quality, originality and impact against university promotion criteria for Associate Professor; evaluating teaching and service record where required; and contributing to the committee's written recommendation on suitability for promotion. 22/06/2025
Committee for the Academic Council of King Saud University (KSU) to assess the research of Dr. Abdullah Al-Hossaini (KSU# 3618), who has applied for promotion to the status of Associate Professor in the Department of Pharmaceutical Chemistry in the College of Pharmacy. As a member of this Academic committee, my duties included reviewing the candidate's publications, research output and academic contributions; assessing their quality, originality and impact against university promotion criteria for Associate Professor; evaluating teaching and service record where required; and contributing to the committee's written recommendation on suitability for promotion. 2023
Reviewer for the Science Fund of the Republic of Serbia, reviewing grant applications for the country 2013
Reviewer of Scientific Journals of very High Impact Factor including Phytochemistry, Phytotherapy Research, Journal of Natural Products, Planta Medica, Plants, Molecules, Plos One, Pharmaceutics, Pharmaceuticals, Antioxidants, Biomedicine and Therapeutics, Frontiers in Pharmacology, Journal of Ethnopharmcology, Brazilian Journal of Pharmacognosy, Journal of Chromatography, Phytochemistry Reviews, Chemistry and Biodiversity, Irish Journal of Medical Sciences, Biomedicine and Pharmacotherapy. since 2000
Head of the Scientific Committee of the 71st International Congress and Annual Meeting of the Society for Medicinal Plant and Natural Product Research (GA). As Head of the Scientific Committee for the 71st GA Congress, my duties included managing the abstract submission process, coordinating peer review and evaluation of submitted abstracts, and selecting 55 oral presentations from 176 submissions based on scientific quality and relevance, ensuring a balanced and high-standard scientific programme for the meeting. July 2023
Associate Editor for Frontiers in Pharmacology. An Associate Editor for Frontiers in Pharmacology handles assigned manuscripts through peer review, selecting reviewers, evaluating review reports, guiding the interactive review/rebuttal process, and making the final acceptance decision; acting independently of Frontiers staff and without financial incentive tied to acceptance outcomes. 2021
External Examiner for the PhD thesis of Joao Vitor da Costa Batista. Faculty of Pharmacy, University of Basel, Switzerland. A PhD external examiner independently reviews the thesis for originality, methodological rigour and contribution to knowledge; prepares a written pre-viva report; conducts (with the internal examiner) the oral viva voce examination, questioning the candidate on their work; assesses whether the degree standard is met; and recommends an outcome; pass, minor/major corrections, or fail; to the university. 31/05/2024
Committee for the Academic Council of Federal University of Rio de Janeiro (UFRJ) to assess the research of Prof. Patricia Dias Fernandes, who has applied for promotion to the status of Adjunct Professor IV in the Department of Pharmacology. As a member of this Academic committee, my duties included reviewing the candidate's publications, research output and academic contributions; assessing their quality, originality and impact against university promotion criteria for Adjunct Professor IV; evaluating teaching and service record where required; and contributing to the committee's written recommendation on suitability for promotion. 2005
External Examiner for the PhD thesis of Maria Christina Braga Nunes Varrichio. Instituto de Quimica da Universidade Federal do Rio de Janeiro. A PhD external examiner independently reviews the thesis for originality, methodological rigour and contribution to knowledge; prepares a written pre-viva report; conducts (with the internal examiner) the oral viva voce examination, questioning the candidate on their work; assesses whether the degree standard is met; and recommends an outcome; pass, minor/major corrections, or fail; to the university. 2004
External Examiner for the PhD thesis of Helna Celia de Ribeiro Passinho. Departamento de Geneticada Universidade Federal do Rio de Janeiro, Brazil. A PhD external examiner independently reviews the thesis for originality, methodological rigour and contribution to knowledge; prepares a written pre-viva report; conducts (with the internal examiner) the oral viva voce examination, questioning the candidate on their work; assesses whether the degree standard is met; and recommends an outcome; pass, minor/major corrections, or fail; to the university. 2002
External Examiner for the PhD thesis of Davyson de Lima Moreira. Nucleo de Pesquisas de Produtos Naturais da Universidade Federal do Rio de Janeiro, Brazil. A PhD external examiner independently reviews the thesis for originality, methodological rigour and contribution to knowledge; prepares a written pre-viva report; conducts (with the internal examiner) the oral viva voce examination, questioning the candidate on their work; assesses whether the degree standard is met; and recommends an outcome; pass, minor/major corrections, or fail; to the university. 1999
External Examiner for the PhD thesis of Alessandra Leda Valverde. Nucleo de Pesquisas de Produtos Naturais da Universidade Federal do Rio de Janeiro, Brazil. A PhD external examiner independently reviews the thesis for originality, methodological rigour and contribution to knowledge; prepares a written pre-viva report; conducts (with the internal examiner) the oral viva voce examination, questioning the candidate on their work; assesses whether the degree standard is met; and recommends an outcome; pass, minor/major corrections, or fail; to the university. 1999
External Examiner for the PhD thesis of Juliana Feijo de Souza Daniel. Instituto de Quimica da Universidade Federal Rural do Rio de Janeiro. A PhD external examiner independently reviews the thesis for originality, methodological rigour and contribution to knowledge; prepares a written pre-viva report; conducts (with the internal examiner) the oral viva voce examination, questioning the candidate on their work; assesses whether the degree standard is met; and recommends an outcome; pass, minor/major corrections, or fail; to the university. 2004
External Examiner for the PhD thesis of Alexandre daSilva Antunes. Nucleo de Pesquisa de Produtos Naturaisda Universidade Federal do Rio de Janeiro. A PhD external examiner independently reviews the thesis for originality, methodological rigour and contribution to knowledge; prepares a written pre-viva report; conducts (with the internal examiner) the oral viva voce examination, questioning the candidate on their work; assesses whether the degree standard is met; and recommends an outcome; pass, minor/major corrections, or fail; to the university. 2005
External Examiner for the PhD thesis of Rosinéia Matinez Melo. Instituto de Quimica da Universidade Federal do Rio de Janeiro. A PhD external examiner independently reviews the thesis for originality, methodological rigour and contribution to knowledge; prepares a written pre-viva report; conducts (with the internal examiner) the oral viva voce examination, questioning the candidate on their work; assesses whether the degree standard is met; and recommends an outcome; pass, minor/major corrections, or fail; to the university. 2005
External Examiner for the PhD thesis of Gabrielle Bangay. Facultad de Farmacia de la Universidad de Alcalá, Spain. A PhD external examiner independently reviews the thesis for originality, methodological rigour and contribution to knowledge; prepares a written pre-viva report; conducts (with the internal examiner) the oral viva voce examination, questioning the candidate on their work; assesses whether the degree standard is met; and recommends an outcome; pass, minor/major corrections, or fail; to the university. 29/09/2025
External Examiner for the PhD thesis of Annarita Cianciusi. Facoltà di Farmacia dell'Università di Genova, Italy. A PhD external examiner independently reviews the thesis for originality, methodological rigour and contribution to knowledge; prepares a written pre-viva report; conducts (with the internal examiner) the oral viva voce examination, questioning the candidate on their work; assesses whether the degree standard is met; and recommends an outcome; pass, minor/major corrections, or fail; to the university. 29/03/2023
External Examiner for the PhD thesis of Eleonora Mustorgi.Facoltà di Farmacia dell'Università di Genova, Italy. A PhD external examiner independently reviews the thesis for originality, methodological rigour and contribution to knowledge; prepares a written pre-viva report; conducts (with the internal examiner) the oral viva voce examination, questioning the candidate on their work; assesses whether the degree standard is met; and recommends an outcome; pass, minor/major corrections, or fail; to the university. 29/03/2023
External Examiner for the PhD thesis of Valeria Iobbi.Facoltà di Farmacia dell'Università di Genova, Italy. A PhD external examiner independently reviews the thesis for originality, methodological rigour and contribution to knowledge; prepares a written pre-viva report; conducts (with the internal examiner) the oral viva voce examination, questioning the candidate on their work; assesses whether the degree standard is met; and recommends an outcome; pass, minor/major corrections, or fail; to the university. 29/03/2023
External Examiner for the PhD thesis of Matteo Uggeri. Facoltà di Farmacia dell'Università di Genova, Italy. A PhD external examiner independently reviews the thesis for originality, methodological rigour and contribution to knowledge; prepares a written pre-viva report; conducts (with the internal examiner) the oral viva voce examination, questioning the candidate on their work; assesses whether the degree standard is met; and recommends an outcome; pass, minor/major corrections, or fail; to the university. 29/03/2023
External Examiner for the PhD thesis of Fotoon Redwan. School of Pharmacy, University College, London, UK. A PhD external examiner independently reviews the thesis for originality, methodological rigour and contribution to knowledge; prepares a written pre-viva report; conducts (with the internal examiner) the oral viva voce examination, questioning the candidate on their work; assesses whether the degree standard is met; and recommends an outcome; pass, minor/major corrections, or fail; to the university. 25/11/2025
External Examiner for the PhD thesis of Leticia Barbosa Santos. Faculdade de Farmacia, Universidade Federal de Minas Gerais, Brazil. A PhD external examiner independently reviews the thesis for originality, methodological rigour and contribution to knowledge; prepares a written pre-viva report; conducts (with the internal examiner) the oral viva voce examination, questioning the candidate on their work; assesses whether the degree standard is met; and recommends an outcome; pass, minor/major corrections, or fail; to the university. 28/06/2024
External Examiner for the PhD thesis of Nivea Cristina Vieira Neves.Faculdade de Farmacia, Universidade Federal de Minas Gerais, Brazil. A PhD external examiner independently reviews the thesis for originality, methodological rigour and contribution to knowledge; prepares a written pre-viva report; conducts (with the internal examiner) the oral viva voce examination, questioning the candidate on their work; assesses whether the degree standard is met; and recommends an outcome; pass, minor/major corrections, or fail; to the university. 13/09/2021
External Examiner for the PhD thesis of Sarah Gomes de Menezes Benevenuto. Faculdade de Medicina Veterinaria e Ciencias Animais, Universidade de Sao Paulo, Brazil. A PhD external examiner independently reviews the thesis for originality, methodological rigour and contribution to knowledge; prepares a written pre-viva report; conducts (with the internal examiner) the oral viva voce examination, questioning the candidate on their work; assesses whether the degree standard is met; and recommends an outcome; pass, minor/major corrections, or fail; to the university. 31/08/2020
Internal Examiner for the PhD thesis of Ciara Smith. School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin, Ireland At TCD, the internal examiner; a member of academic staff (not the supervisor, though possibly on the Thesis Committee); independently reads and evaluates the thesis, arranges the viva voce date with School administrative staff, liaises directly with the external examiner, jointly conducts and questions the candidate at the viva, and reaches a joint recommendation on the outcome. 12/10/2022
Internal Examiner for the PhD thesis of Kit Chan.School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin, Ireland At TCD, the internal examiner; a member of academic staff (not the supervisor, though possibly on the Thesis Committee); independently reads and evaluates the thesis, arranges the viva voce date with School administrative staff, liaises directly with the external examiner, jointly conducts and questions the candidate at the viva, and reaches a joint recommendation on the outcome. 11/09/2017
PhD Thesis committee for Sukanya Jana. School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin, Ireland. A Thesis Committee supports the student's academic progress and guidance as a PhD researcher; assesses and monitors research through formal annual review and confirmation/transfer interviews, agreeing recommendations on continuation; and supports the student-supervisor relationship, enhancing the overall quality and rigour of supervision throughout the structured PhD. 09/24-09/28
PhD Thesis committee for Fiona Hedigan. School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin, Ireland. A Thesis Committee supports the student's academic progress and guidance as a PhD researcher; assesses and monitors research through formal annual review and confirmation/transfer interviews, agreeing recommendations on continuation; and supports the student-supervisor relationship, enhancing the overall quality and rigour of supervision throughout the structured PhD. 09/20-01/25
PhD thesis committee for the student Kate Tolan. School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin, Ireland. A Thesis Committee supports the student's academic progress and guidance as a PhD researcher; assesses and monitors research through formal annual review and confirmation/transfer interviews, agreeing recommendations on continuation; and supports the student-supervisor relationship, enhancing the overall quality and rigour of supervision throughout the structured PhD. 09/21-11/25
Ad hoc Consultant for CNPq - National Council for Scientific and Technological Development, Brazil. An Ad Hoc Consultant issues detailed written opinions on the scientific/academic merit of grant, scholarship and project applications; monitors and evaluates funded projects' progress reports; may visit institutions for follow-up assessment; meets deadlines; and maintains strict confidentiality regarding the material reviewed. 2005-2007
Language Skill Reading Skill Writing Skill Speaking
English Fluent Fluent Fluent
French Fluent Basic Medium
Italian Fluent Medium Medium
Portuguese Fluent Fluent Fluent
Spanish Fluent Medium Medium
Details Date From Date To
Secretary of the Phytochemical Society of Portugal 2026
Phytochemical Society of North America 1992
Brazilian Society of Pharmacognosy 2000
GA - Society for Medicinal Plant and Natural Product Research 2022
Bashaer Alsharif, Matilde Biasiotti, Ammar Bader, Wirginia Kukula-Koch, Gavin P Davey, Fabio Boylan, Acetylcholinesterase and monoamine oxidase inhibitory activities of Pistacia falcata Becc. ex Martelli extract, Nat Prod Res ., 2025, Journal Article, PUBLISHED  DOI
Neves NCV, de Mello MP, Smith SM, Boylan F, Caliari MV, Castilho RO., Bioactive properties of Campomanesia lineatifolia: correlation between anti-Helicobacter pylori activity, antioxidant potential and chemical composition, Plants, 13, (22), 2024, p3117-, Journal Article, PUBLISHED  DOI
Tan A, Scortecci K, De Medeiros NMC, Kukula-Koch W, Butler TJ, Smith SM, Boylan F., Plukenetia volubilis Leaves as Source of anti-Helicobacter pylori agents., Frontiers in Pharmacology, 15, (1461447), 2024, Journal Article, PUBLISHED  DOI
Banchong Y, Leepasert T, Jarupund P, Hodkinson TR, Boylan F, Suwanphakdee C., Chemotaxonomy of Southeast Asian Peperomia (Piperaceae) Using High-Performance Thin-Layer Chromatography Colour Scale Fingerprint Imaging and Gas Chromatography-Mass Spectrometry, Plants, 13, (19), 2024, p2751 , Journal Article, PUBLISHED  DOI  URL
Mladenovic Marko Z, Ristic Milenko N, Bogdanovic Andrija I, Ristic Novica R, Boylan Fabi, Radulovic Niko S, Wax Composition of Serbian Dianthus spp. (Caryophyllaceae): Identification of New Metabolites and Chemotaxonomic Implications, PLANTS-BASEL, 12, (11), 2023, Journal Article, PUBLISHED  DOI
Silveira Damari, Boylan Fabio, Medicinal Plants: Advances in Phytochemistry and Ethnobotany, PLANTS-BASEL, 12, (8), 2023, Journal Article, PUBLISHED  DOI
Fernandes Felipe Hugo Alenca, Soares Sabrina da Silv, Bekbolatova Elmir, Boylan Fabio, Salgado Herida Regina Nune, Pharmacological, toxicological and phytochemical analysis of Spondias dulcis parkinson, Natural Product Research, 38, (6), 2024, p10149 - 1053, Journal Article, PUBLISHED  DOI
Radulovic Niko S, Mladenovic Marko Z, Dekic Milan S, Boylan Fabio, Synthesis of Small Libraries of Natural Products: Part II: Identification of a New Natural Product from the Essential Oil of Pleurospermum austriacum (L.) Hoffm. (Apiaceae), MOLECULES, 28, (12), 2023, Journal Article, PUBLISHED  DOI
MENSOR, L. L. ; MENEZES, F. S. ; LEITÃO, Gilda Guimarães ; REIS, A. S. ; SANTOS, T. C. ; COUBE, C. S. ; LEITÃO, Suzana Guimarães , Screening of Brazilian Plant Extracts for Antioxidant Activity by the Use of DPPH Free Radical Method, Phytotherapy Research, 15, (2), 2001, p127 - 130, Journal Article, PUBLISHED  DOI
SILVA, Carmelita G ; HERDEIRO, R S ; MATHIAS, C J ; PANEK, Anita Dolly ; SILVEIRA, Cristiane Silva ; RODRIGUES, Verônica Pinto ; RENNÓ, Magdalena Nascimento ; FALCÃO, Deborah Quintanilha ; CERQUEIRA, Débora Malta ; MINTO, Andréa Barreto Mattos ; NOGUEIRA, Fábio Luis Pereira ; QUARESMA, Carla Holandino ; SILVA, Joaquim Fernando Mendes da ; MENEZES, F. S. ; ELEUTHERIO, Elis Cristina de Araújo, Evaluation of Antioxidant Activity of Brazilian Plants, Pharmacological Research, 52, (3), 2005, p229 - 233, Journal Article, PUBLISHED  DOI
  

Page 1 of 37
Fabio Boylan, School of Pharmacy and Pharmaceutical Sciences - International Experience, Meeting with the University of Qatar, TCD, 27/06/2024, 2024, Invited Talk, PRESENTED
Fabio Boylan, Science, Information and Pharmaceutical Assistance: Guarantee of the Rational Use of Medicines, Pharmacists as Frontline Public Advocates: A Pathway to Impact, TCD, 23/02/2025, 2025, Invited Talk, PRESENTED
Fabio Boylan, Natural Products as source of Drug discovery, Invited Seminars to the Lusofona University of Lisbon, Lisbon, 03/03/2026, 2026, Lusofona University of Lisbon, Invited Talk, PRESENTED

  


Award Date
Cum Laude Diploma 1992
Research Productivity Fellowship issued by the National Council for Scientific and Technological Development (CNPq), Brazil. 2004-2006
Postdoctoral Fellowship by the Coordination for the Improvement of Higher Education Personnel, Brazil to go to TCD 2006
Global Relations Certificate of Excellence 2015-2016
Piece on my Research featured in the TCD Provost"s annual review 2016-2017
Associate Academic Director of NatPro Centre 2020
The NatPro Centre, where I am the Associate Academic Director, was awarded the highest Level of Green Certification by MyGreenLab, a non-profit organisation focusing on building a global culture of sustainability in science. This timely award will contribute to TCD"s ongoing efforts to expand its sustainability and Green Footprint. 2022
Honorary Professor awarded by the Kazakh National Medical University due to my years of excellence in teaching as a visiting professor and outstanding achievements with their MSc. and PhD students 2025
Over the past 25 years, my work in pharmacognosy and ethnopharmacology has built an internationally recognised research profile at the intersection of traditional medical knowledge and modern pharmaceutical science, centred on discovering, chemically characterising, and pharmacologically validating bioactive natural products, with a particular focus on essential oils and volatile organic compounds, informing therapeutic strategies for some of the most pressing challenges in global health, from antimicrobial resistance to inflammation and cancer. The scale of this output speaks for itself: 145 peer-reviewed journal articles (105 as senior author), a Google Scholar h-index of 34, an i10-index of 78, and more than 6,909 citations. Among these, a study examining natural products during the COVID-19 pandemic has had particular resonance, reshaping how risk-benefit assessments are approached in international health emergencies, drawing over 389,200 views and 23,800 downloads worldwide. None of this would have been possible without years spent mentoring postgraduate researchers and building research consortia that span continents. Taking up the role of Professor In, I intend to draw on this international standing, including a 2025 Honorary Professorship awarded by the Kazakh National Medical University, to definitely consolidate Trinity College Dublin as a leading global centre for natural product drug discovery. My research agenda speaks directly to Trinity's priorities around One Health, sustainability, and innovation, exploring the chemical ecology and therapeutic potential of under-studied biodiversity in Portugal, Brazil, Saudi Arabia, and Kazakhstan. Bringing together advanced analytical chemistry, metabolomics, and molecular pharmacology, my group will keep translating natural products into real therapeutic candidates, securing competitive funding, strong postgraduate training, and lasting benefit to the wider pharmaceutical community. The sustained competitive pressure against natural-product proposals in mainstream EU calls, well documented in the field's own literature, has driven me to diversify aggressively into national, bilateral, and philanthropic funding, COST Actions, and non-EU schemes.